Proteomic analysis of exosomes isolated from body fluids has revealed upregulation of ITGB4. This finding suggests that ITGB4 may serve as a potential biomarker for prostate cancer progression and taxane resistance. The gene discussed is ITGB4; the disease is prostate carcinoma.